Kura Oncology, Inc. (KURA) Financials

KURA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 587.8 million 539.4 million
March 31, 2026 652.6 million 544.7 million
Dec. 31, 2025 738.4 million 564.2 million
Sept. 30, 2025 649.4 million 406.8 million

KURA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -63.2 million 8.2 million
March 31, 2026 -86.0 million 8.4 million
Dec. 31, 2025 115.0 million 11.4 million
Sept. 30, 2025 -83.2 million 11.0 million

KURA Net Income

No data available :(

KURA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 519.0 million 5.6 million 14.7 million
March 31, 2026 580.8 million 9.7 million 13.2 million
Dec. 31, 2025 667.2 million 9.7 million 9.5 million
Sept. 30, 2025 549.7 million 5.3 million 9.8 million

KURA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 88.9 million
March 31, 2026 88.6 million
Dec. 31, 2025 88.1 million
Sept. 30, 2025 87.6 million

KURA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 656000 61.9 million 31.8 million -
March 31, 2026 128000 65.3 million 31.2 million -
Dec. 31, 2025 2.3 million 64.4 million 39.1 million -
Sept. 30, 2025 2.6 million 67.9 million 32.8 million -

KURA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 20.9 million 243000
March 31, 2026 18.3 million 617000
Dec. 31, 2025 17.3 million 460000
Sept. 30, 2025 20.8 million 3.2 million

KURA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

KURA

Price: $10.86

52 week price:
5.45
12.49

Earnings Per Share: -3.42 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 495600

Ebitda: -9.1 million

Market Capitalization: 897.6 million

Links: